HETEROCYCLIC AMINOALKYL PYRIDINE DERIVATIVES AS PSYCHOPHARMACEUTICALS

摘要

The invention relates to heterocyclic aminoalkylpyridine derivatives of the formula I: where R¹ is the radical of a heterocycle having 1 to 3 ring structures, where each ring structure is saturated, unsaturated or aromatic and optionally fused to other ring structures to give a fused ring system and the heterocycle has a total of 1 to 4 N, O and/or S atoms in the ring structures and is optionally monosubstituted, disubstituted or trisubstituted by one or more of the groups -A, -OR⁴, -N(R⁴)₂, -NO₂, -CN, Hal, -COOR⁴, -CON(R⁴)₂, -COR⁴, -O; R² is a phenyl group which is optionally monosubstituted, disubstituted, trisubstituted, tetrasubstituted or pentasubstituted by one or more of the groups Hal, -A, -O-A, -NO₂ or -CN, or is a thienyl group which is optionally monosubstituted or disubstituted by one or more of the groups Hal, -A, -O-A, -NO₂, -CN or thienyl; R³ is H, -A, -CO-A, -C(R⁴)₂R², -C(R⁴)₂-pyridinediyl-R²; R⁴ is H or -A; A is C₁-C₆-alkyl, where 1 to 7 hydrogen atoms are optionally replaced by fluorine; -X- is -O-, -S-, sulfinyl, sulfonyl, -C(R⁴)₂-; -Y- is -[C(R⁴)₂]_n-; -Z- is -C(R⁴)₂-; Hal is F, Cl, Br or I; n is 1, 2, 3 or 4; and their tolerable salts and solvates and their use as medicaments.